The aim is to evaluate Trop2 expression across different molecular subtypes of breast cancer and assess the efficacy of a new imaging tracer.
Evaluated Trop2 expression using a novel tracer, [<sup>18</sup>F]AlF-RESCA-RT4.
Performed imaging across various molecular subtypes of breast cancer.
Compared diagnostic performance against standard imaging techniques.
Trop2 expression was higher in aggressive subtypes, indicating a potential diagnostic marker.
The novel tracer provided enhanced imaging clarity compared to traditional methods.
Significant improvement in diagnosis of metastases was observed, enhancing treatment planning.
Abstract
This study aimed to evaluate human trophoblast cell surface antigen 2 (Trop2) expression across molecular subtypes of breast cancer and assess the diagnostic performance of a novel Trop2-targeted tracer, [